Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare organic aciduria characterized by impaired isoleucine degradation with increased plasma or whole blood C5 acylcarnitine levels (typically observed in newborn screening) and increased urinary excretion of N-methylbutyrylglycine. The condition is usually clinically asymptomatic, although patients with muscular hypotonia, developmental delay, and seizures (among others) have been reported.
Features include always present findings: Low muscle tone (hypotonia), Motor delay, 2-ethylhydracylic aciduria, and Generalized amyotrophy. 12 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Seizure, Global developmental delay |
Head and neck | 1 | Microcephaly |
Muscles | 1 | Low muscle tone (hypotonia) |
ACADSB encodes acyl-CoA dehydrogenase short/branched chain (432 aa). Short and branched chain specific acyl-CoA dehydrogenase that catalyzes the proR-proR stereospecific alpha,beta-dehydrogenation of fatty acyl-CoA thioesters using the electron transfer flavoprotein (ETF) as their physiologic electron acceptor, resulting in the formation of trans-2-enoyl-CoA ((2E)-enoyl-CoA). Highest expression in Liver (97.0 TPM) and Brain Cerebellar Hemisphere (38.0 TPM).
2-methylbutyryl-CoA dehydrogenase deficiency is caused by mutations in the ACADSB gene on chromosome 10.
The ACADSB protein participates in alpha-methylbutyryl-CoA + FAD = tiglyl-CoA + FADH2 pathway.
ACADSB is classified as a druggable target (Enzyme category) with score 1.6.
52 pathogenic variants reported in ACADSB in ClinVar, including hotspot variants 4360895 and LRG_451p1:p.Met389Val (2-star review).
Variant | Significance | Review Stars | Hotspot |
|---|---|---|---|
4360895 | Likely pathogenic | — | Yes |
LRG_451p1:p.Met389Val | Pathogenic | 2 stars | Yes |
NP_001317103.1:p.Glu24fs | Pathogenic/Likely pathogenic | 2 stars | Yes |
448980 | Pathogenic/Likely pathogenic | 2 stars | Yes |
LRG_451p1:p.Trp207Ter | Pathogenic/Likely pathogenic | 2 stars | Yes |
Genetic testing for ACADSB is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for 2-methylbutyryl-CoA dehydrogenase deficiency has been reported in the published literature.
Phenotype severity distribution: 4 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for 2-methylbutyryl-CoA dehydrogenase deficiency.
10 publications have been identified in PubMed for 2-methylbutyryl-CoA dehydrogenase deficiency. Research spans Diagnostic / Biomarker (40%), Epidemiology / Natural History (40%), and Review / Meta-Analysis (10%).
Research Type | Count | % of Total |
|---|---|---|
Testing and diagnosis research | 4 | 40% |
Disease patterns and progression | 4 | 40% |
Research summaries | 1 | 10% |
Laboratory research | 1 | 10% |
Nasri M (2026). [PMID: 41527137](https://pubmed.ncbi.nlm.nih.gov/41527137/). *Orphanet journal of rare diseases*. [Diagnostic / Biomarker]
Lin Y (2026). [PMID: 41892026](https://pubmed.ncbi.nlm.nih.gov/41892026/). *Int J Neonatal Screen*. [Diagnostic / Biomarker]
Zhang H (2025). [PMID: 40727585](https://pubmed.ncbi.nlm.nih.gov/40727585/). *Frontiers in genetics*. [Review / Meta-Analysis]
Idárraga GDO (2025). [PMID: 40080775](https://pubmed.ncbi.nlm.nih.gov/40080775/). *JBRA assisted reproduction*. [Epidemiology / Natural History]
Hong S (2025). [PMID: 40618281](https://pubmed.ncbi.nlm.nih.gov/40618281/). *Human molecular genetics*. [Basic Science / Preclinical]
Lin Y (2025). [PMID: 40835664](https://pubmed.ncbi.nlm.nih.gov/40835664/). *Scientific reports*. [Epidemiology / Natural History]
Huang S (2025). [PMID: 41440809](https://pubmed.ncbi.nlm.nih.gov/41440809/). *International journal of neonatal screening*. [Epidemiology / Natural History]
Ou MM (2025). [PMID: 41357791](https://pubmed.ncbi.nlm.nih.gov/41357791/). *Frontiers in pediatrics*. [Diagnostic / Biomarker]
Liu H (2025). [PMID: 40598537](https://pubmed.ncbi.nlm.nih.gov/40598537/). *Orphanet journal of rare diseases*. [Diagnostic / Biomarker]
Xiao G (2024). [PMID: 38784038](https://pubmed.ncbi.nlm.nih.gov/38784038/). *Frontiers in genetics*. [Epidemiology / Natural History]
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 7:55 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center